Trial Profile
Multicenter Phase II Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2013
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 24 Mar 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jan 2009 Planned end date changed from 1 Jan 2008 to 1 Jan 2010, as reported by ClinicalTrials.gov.